Pfizer’s stock drops as earnings fall sharply amid lower sales for its COVID products

Pfizer's stock was down premarket as earnings hit by lower demand for its COVID products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.